Core Viewpoint - The company, Mediwake (02159), announced a non-binding memorandum of understanding regarding the potential acquisition of 100% equity in Hong Kong Huanyu Medical Technology Development Co., Ltd. and its subsidiaries, referred to as the "Target Group" [1] Group 1: Acquisition Details - The memorandum was signed on January 20, 2026, between the company's subsidiary and a potential seller [1] - The Target Group primarily provides artificial intelligence technology to global pharmaceutical and medical device companies [1] Group 2: Technology and Solutions - The Target Group aims to innovate pharmaceutical research and physician training through its specialized AI medical models [1] - It utilizes Web3 core blockchain technology to ensure data authenticity, security, and traceability [1]
麦迪卫康(02159)附属有意收购香港寰宇医诚智慧科技发展100%股权